Advertisement
Clinical and Epidemiological Investigations

Appearance and Phenotypic Characterization of Circulating Leu 19+ Cells in Cancer Patients Receiving Recombinant Interleukin 2

Thomas M. Ellis, Stephen P. Creekmore, John D. McMannis, Donald P. Braun, Jules A. Harris and Richard I. Fisher
DOI:  Published November 1988

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to January 2021

AbstractFull-text HTMLPDF
Total5433391

Cited By

Article Information

Volume 48, Issue 22, pp. 6597-6602

PubMed 
2902918
Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445
History 
  • Received May 10, 1988
  • Revision received July 18, 1988
  • Accepted August 10, 1988
  • Published first November 1, 1988.
Copyright & Usage 
©1988 American Association for Cancer Research.

Author Information

  1. Thomas M. Ellis2,
  2. Stephen P. Creekmore,
  3. John D. McMannis,
  4. Donald P. Braun,
  5. Jules A. Harris, and
  6. Richard I. Fisher
  1. Section of Hematology/Oncology, Loyola University Stritch School of Medicine, Maywood, Illinois 60153 [T. M. E., S. P. C., J. D. M., R. I. F.]; Section of Medical Oncology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612 [D. P. B., J. A. H.]; and Illinois Cancer Council, Chicago, Illinois 60603 [T. M. E., S. P. C., J. D. M., D. P. B., J. A. H., R. I. F.]
Back to top

Open full page PDF
Article Alerts
Email Article
Citation Tools
Appearance and Phenotypic Characterization of Circulating Leu 19+ Cells in Cancer Patients Receiving Recombinant Interleukin 2
Thomas M. Ellis, Stephen P. Creekmore, John D. McMannis, Donald P. Braun, Jules A. Harris and Richard I. Fisher
Cancer Res November 15 1988 (48) (22) 6597-6602;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement